These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37957199)

  • 21. Identification and characterization of severe familial hypercholesterolemia in patients presenting for cardiac catheterization.
    Zafrir B; Shapira C; Lavie G; Halon DA; Flugelman MY
    J Clin Lipidol; 2016; 10(6):1338-1343. PubMed ID: 27919350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal Inheritance of Familial Hypercholesterolemia Gene Mutation Predisposes to Coronary Atherosclerosis as Assessed by Calcium Score in Adulthood.
    Mourre F; Giorgi R; Gallo A; Boccara F; Bruckert E; Carrié A; Hankard R; Inamo J; Laboureau S; Moulin P; Valéro R; Béliard S;
    Arterioscler Thromb Vasc Biol; 2023 Feb; 43(2):e94-e103. PubMed ID: 36579650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia.
    Trinder M; Li X; DeCastro ML; Cermakova L; Sadananda S; Jackson LM; Azizi H; Mancini GBJ; Francis GA; Frohlich J; Brunham LR
    J Am Coll Cardiol; 2019 Jul; 74(4):512-522. PubMed ID: 31345425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of cardiovascular disease outcomes in primary care subjects with familial hypercholesterolaemia: A cohort study.
    Iyen B; Qureshi N; Kai J; Akyea RK; Leonardi-Bee J; Roderick P; Humphries SE; Weng S
    Atherosclerosis; 2019 Aug; 287():8-15. PubMed ID: 31181417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia.
    Du Z; Li F; Jiang L; Li L; Du Y; Yu H; Luo Y; Wang Y; Sun H; Hu C; Li J; Yang Y; Jiao X; Wang L; Qin Y
    BMC Med; 2023 Jul; 21(1):275. PubMed ID: 37501168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
    Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW
    Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atherosclerotic cardiovascular disease burden in patients with familial hypercholesterolemia: interpretation of data on involvement of different vascular beds.
    Dobrowolski P; Kabat M; Kępka C; Januszewicz A; Prejbisz A
    Pol Arch Intern Med; 2022 Apr; 132(4):. PubMed ID: 35485652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals.
    Dyrbuś K; Gąsior M; Desperak P; Osadnik T; Nowak J; Banach M
    Atherosclerosis; 2019 Sep; 288():33-41. PubMed ID: 31319356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lipid profile, familial hypercholesterolemia prevalence, and 2-year cardiovascular outcome assessment in acute coronary syndrome: Real-life data of a retrospective cohort].
    Kayikcioglu M; Alan B; Payzın S; Can LH
    Turk Kardiyol Dern Ars; 2019 Sep; 47(6):476-486. PubMed ID: 31483296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH.
    Anagnostis P; Rizos CV; Skoumas I; Rallidis L; Tziomalos K; Skalidis E; Kotsis V; Doumas M; Kolovou G; Sfikas G; Garoufi A; Lambadiari V; Dima I; Kiouri E; Agapakis D; Zacharis E; Antza C; Kolovou V; Koumaras C; Bantouvakis G; Liamis G; Liberopoulos EN
    Endocrine; 2022 May; 76(2):324-330. PubMed ID: 35262845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes.
    Nanchen D; Gencer B; Muller O; Auer R; Aghlmandi S; Heg D; Klingenberg R; Räber L; Carballo D; Carballo S; Matter CM; Lüscher TF; Windecker S; Mach F; Rodondi N
    Circulation; 2016 Sep; 134(10):698-709. PubMed ID: 27462068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of genetic testing on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia (GenTLe-FH): a randomised waiting list controlled open-label study protocol.
    Nomura A; Tada H; Okada H; Nohara A; Ishikawa H; Yoshimura K; Kawashiri MA
    BMJ Open; 2018 Dec; 8(12):e023636. PubMed ID: 30593551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hidden Burden of Electronic Health Record-Identified Familial Hypercholesterolemia: Clinical Outcomes and Cost of Medical Care.
    Patel P; Hu Y; Kolinovsky A; Geng Z; Ruhl J; Krishnamurthy S; deRichemond C; Khan A; Kirchner HL; Metpally R; Jones LK; Sturm AC; Carey D; Snyder S; Williams MS; Mehra VC
    J Am Heart Assoc; 2019 Jul; 8(13):e011822. PubMed ID: 31256702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial Hypercholesterolemia Among Young Adults With Acute Coronary Syndrome.
    Haskiah F; Erez D; Khaskia A
    Am J Cardiol; 2023 Jan; 186():189-195. PubMed ID: 36270825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of cardiovascular risk factors in patients with familial hypercholesterolemia from the North-Eastern area of Romania.
    Vlad CE; Foia L; Florea L; Costache II; Covic A; Popescu R; Reurean-Pintilei D; Covic A
    Lipids Health Dis; 2021 Jan; 20(1):4. PubMed ID: 33430859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study.
    Harada-Shiba M; Ako J; Arai H; Hirayama A; Murakami Y; Nohara A; Ozaki A; Uno K; Nakamura M
    Atherosclerosis; 2018 Oct; 277():362-368. PubMed ID: 30270072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease: The POSTER study.
    Gulizia MM; Maggioni AP; Abrignani MG; Bilato C; Mangiacapra F; Sanchez FA; Piovaccari G; Montagna L; Marini M; De Biasio M; Averna M; Casula M; Colivicchi F; Fabbri G; Lucci D; Zampoleri V; Catapano AL;
    Atherosclerosis; 2020 Sep; 308():32-38. PubMed ID: 32823190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention.
    Tscharre M; Herman R; Rohla M; Piackova E; Vargas KG; Farhan S; Freynhofer MK; Weiss TW; Huber K
    J Clin Lipidol; 2019; 13(1):115-122. PubMed ID: 30344049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of cascade screening for familial hypercholesterolemia on cardiovascular events.
    Tada H; Okada H; Nomura A; Nohara A; Yamagishi M; Takamura M; Kawashiri MA
    J Clin Lipidol; 2021; 15(2):358-365. PubMed ID: 33461934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploration into lipid management and persistent risk in patients hospitalised for acute coronary syndrome in Japan (EXPLORE-J): protocol for a prospective observational study.
    Nakamura M; Uno K; Hirayama A; Ako J; Nohara A; Arai H; Harada-Shiba M
    BMJ Open; 2017 Jul; 7(6):e014427. PubMed ID: 28674132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.